Hunan Er-Kang Pharmaceutical Co.,Ltd.’s Net Profit Dropped 20.9% in First Three Quarters of 2023

Hunan Er-Kang Pharmaceutical Co.,Ltd. (湖南尔康制药股份有限公司) (300267.SZ) reported a net profit of 24 million yuan in the first three quarters of 2023, down 20.9% year-on-year.

Meanwhile, the company posted 1.4 billion yuan in revenue, up 9.7% year-on-year.

At the end of the reporting period, it had 5.5 billion yuan in total assets and 457.6 million yuan in total liabilities, with a liability-to-asset ratio of 8.3%.